16-57245397-GCTGT-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_012106.4(ARL2BP):c.33_36del(p.Phe13ProfsTer15) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
ARL2BP
NM_012106.4 frameshift
NM_012106.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.82
Genes affected
ARL2BP (HGNC:17146): (ADP ribosylation factor like GTPase 2 binding protein) ADP-ribosylation factor (ARF)-like proteins (ARLs) comprise a functionally distinct group of the ARF family of RAS-related GTPases. The protein encoded by this gene binds to ARL2.GTP with high affinity but does not interact with ARL2.GDP, activated ARF, or RHO proteins. The lack of detectable membrane association of this protein or ARL2 upon activation of ARL2 is suggestive of actions distinct from those of the ARFs. This protein is considered to be the first ARL2-specific effector identified, due to its interaction with ARL2.GTP but lack of ARL2 GTPase-activating protein activity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.937 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-57245397-GCTGT-G is Pathogenic according to our data. Variant chr16-57245397-GCTGT-G is described in ClinVar as [Pathogenic]. Clinvar id is 2577503.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL2BP | NM_012106.4 | c.33_36del | p.Phe13ProfsTer15 | frameshift_variant | 1/6 | ENST00000219204.8 | NP_036238.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL2BP | ENST00000219204.8 | c.33_36del | p.Phe13ProfsTer15 | frameshift_variant | 1/6 | 1 | NM_012106.4 | ENSP00000219204 | P1 | |
ARL2BP | ENST00000562023.5 | c.33_36del | p.Phe13ProfsTer15 | frameshift_variant | 1/5 | 3 | ENSP00000457465 | |||
ARL2BP | ENST00000563234.1 | c.25_28del | p.Phe11ProfsTer15 | frameshift_variant | 1/6 | 2 | ENSP00000454237 | |||
ARL2BP | ENST00000565794.1 | n.142_145del | non_coding_transcript_exon_variant | 1/2 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Retinitis pigmentosa with or without situs inversus Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 27, 2024 | - - |
Retinitis pigmentosa Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel | Jul 24, 2023 | Clinical significance based on ACMG v2.0 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.